$CTMX
CytomX Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
CytomX Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is CTMX up today? It is at $2.04 (+8.24%), and our scanner flagged it 157 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CTMX spikes, and full due diligence on CTMX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CTMX 157 times in the last 30 days. Create a free account to track $CTMX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CTMX from our scanner (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on CTMX today, peaking at 27.4x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystCytomX Therapeutics Announces Q3 2026 Financial Results and ProvidesReported CytomX ended Q3 2026 with $348.0 million of cash, cash equivalents and investments with expected cash runway into the second half of 2028. Cash, cash equivalents and short-term investments totaled $330.3 million as of Q2 2026.Reported Total operating expense for the quarter ended September 30, 2026 was $25.2 million compared to $21.7 million for the quarter ended September 30, 2025, an increase of $3.5 million., from an SEC filing. Read it →We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carvajal Alejandra Officer | Acquired (grant/award) | +100K 0.05% of company | n/a | 100K | n/a | Aug 3, 26 |
Ogden Christopher Officer | Sold (automatic/other) | -2K | sold 0.5% | 295K | $5K at $3.05 | Jun 15, 26 |
Ogden Christopher Officer | Sold (automatic/other) | -19K | sold 6.1% | 297K | $124K at $6.42 | Mar 17, 26 |
Belvin Marcia Officer | Sold (automatic/other) | -31K 0.01% of company | sold 9.5% | 301K | $202K at $6.42 | Mar 17, 26 |
Mccarthy Sean A. Officer | Sold (automatic/other) | -119K 0.05% of company | sold 9.9% | 1.08M | $764K at $6.42 | Mar 17, 26 |
Chu Yu-Waye Officer | Sold (automatic/other) | -21K | sold 10% | 189K | $137K at $6.42 | Mar 17, 26 |
Mccarthy Sean A. Officer | Acquired (grant/award) | +210K 0.10% of company | added 21% | 1.20M | n/a | Feb 2, 26 |
Ogden Christopher Officer | Acquired (grant/award) | +90K 0.04% of company | added 40% | 316K | n/a | Feb 2, 26 |
Belvin Marcia Officer | Acquired (grant/award) | +60K 0.03% of company | added 22% | 332K | n/a | Feb 2, 26 |
Chu Yu-Waye Officer | Acquired (grant/award) | +75K 0.03% of company | added 55% | 211K | n/a | Feb 2, 26 |
Lester Rachael Officer | Acquired (grant/award) | +20K | n/a | 20K | n/a | Feb 2, 26 |
Mccarthy Sean A. Officer | Sold (automatic/other) | -102K 0.05% of company | sold 9.3% | 988K | $462K at $4.54 | Nov 6, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CTMX from our scanner (live price and day move above). Our scanner has fired 15 unusual-volume and momentum alerts on CTMX today, peaking at 27.4x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
CTMX last traded at $2.04, up 8.24% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The CTMX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CTMX 157 times in the last 30 days.
CTMX (CytomX Therapeutics, Inc.) trades on XNAS, with a market cap of about $410M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CTMX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CTMX discussion
Sign in to ask a question or join the discussion.